Literature DB >> 10619541

Psychopathy and depression: mutually exclusive constructs?

L Lovelace1, L Gannon.   

Abstract

The present study was designed to evaluate the nature of the differences between psychopathy and depression. Based on previously articulated theoretical models, we hypothesized an inverse relationship between the two clinical constructs. Archival data were retrieved from 231 outpatient clients who had completed measures of depression and psychopathy. Correlational analyses and ANOVA's based on extreme groups supported the hypothesis. Implications for assessment, treatment, and research methodology are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10619541     DOI: 10.1016/s0005-7916(99)00022-1

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  4 in total

1.  The effects of sertraline on psychopathic traits.

Authors:  Boadie W Dunlop; Jared A DeFife; Lauren Marx; Steven J Garlow; Charles B Nemeroff; Scott O Lilienfeld
Journal:  Int Clin Psychopharmacol       Date:  2011-11       Impact factor: 1.659

2.  Processing of differentially valued rewards and punishments in youths with bipolar disorder or severe mood dysregulation.

Authors:  Geoff Rau; Karina S Blair; Lisa Berghorst; Lisa Knopf; Martha Skup; David A Luckenbaugh; Daniel S Pine; Robert J Blair; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-04       Impact factor: 2.576

3.  Callous-Unemotional Traits as an Intervention Target and Moderator of Parent-Child Interaction Therapy-Emotion Development Treatment for Preschool Depression and Conduct Problems.

Authors:  Meghan Rose Donohue; Caroline P Hoyniak; Rebecca Tillman; Deanna M Barch; Joan Luby
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-05-20       Impact factor: 13.113

4.  Relationship between the Dark Triad and depressive symptoms.

Authors:  Raquel Gómez-Leal; Alberto Megías-Robles; María José Gutiérrez-Cobo; Rosario Cabello; Enrique G Fernández-Abascal; Pablo Fernández-Berrocal
Journal:  PeerJ       Date:  2019-11-29       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.